ClinicalTrials.gg
CompletedNCT03475784Updated Aug 20, 2019

Two Fluid Strategies for Prevention of Post-dural Puncture Headache

A Phase 3 interventional study of Restrictive fluid therapy and Liberal fluid therapy in Post-Dural Puncture Headache, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2019-08-20.

Sponsored by Cairo University · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 31 studies in Post-Dural Puncture Headache with a site in Egypt — 5 open to participants now, 6 under way, 1 of them phase 3. Post-Dural Puncture Headache · Egypt.

Enrollment
13th of 29
100 · median 75
Started
2018
with 4 others
Phase 3
3 of 31
none open now
Registered
2nd of 31
by date
Lead sponsor
2 of 31
Cairo University

Among the 31 studies in Post-Dural Puncture Headache with a site in Egypt, this one is the 13th largest by enrollment of the 29 interventional ones that give a count, is one of 5 that started in 2018, is one of 3 in phase 3, and was the 2nd registered.

Post-Dural Puncture Headache

122 studies on the registry are indexed under Post-Dural Puncture Headache; 27 are open to participants now.

Browse Post-Dural Puncture Headache studies →

Open to participants now

5 of the 31 studies in Post-Dural Puncture Headache with a site in Egypt are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 15 Post-Dural Puncture Headache studies recruiting now, 7 (47%) set no upper age limit and 8 (53%) stop at 75 or younger; 1 takes children under 18; none take healthy volunteers.

This study: 18 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Post-Dural Puncture Headache with a site in Egypt, or all of them as a file.
02

Study summary

Postdural puncture headache (PDPH) is a common complication after cesarean delivery (CD). The role of peri-operative fluid therapy in prophylaxis against PDPH is unclear. The aim of this work is to compare restrictive versus liberal fluid therapy in prophylaxis against PDPH after CD

Read the detailed description

In this study, the investigators will compare restrictive fluid therapy and liberal fluid therapy in prophylaxis against postdural puncture headache.

The restrictive group will not receive preoperative fluid loading, and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2 mL/Kg/hour for hours. The Liberal group will receive preoperative fluid loading of 5 mL/Kg, and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour, followed by postoperative crystalloids at rate of 6 mL/Kg/hour.

Both groups will be compared regarding demographic data, total peri-operative fluids, incidence of postdural puncture headache, nausea, vomiting, and intraoperative hemodynamics (heart rate and systolic blood pressure) in addition to neonatal outcomes.

03

Conditions studied

  • Post-Dural Puncture Headache
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full term
  • Pregnant female
  • Scheduled to elective cesarean delivery

Exclusion criteria

Exclusion Criteria:

  • History of migraine headache
  • Hypertensive disorders of pregnancy
  • Cardiac morbidities,
  • Baseline systolic blood pressure \< 100 mmHg
  • of regional anesthesia.
  • Patients with more than one single attempt for spinal block
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Restricted fluid therapy group

    Restrictive fluid therapy: this group will not receive fluid pre-load, and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2mL/Kg/hour.

    Drug: Restrictive fluid therapy

  • Active comparator
    Liberal fluid therapy group

    Liberal fluid therapy: this group will receive fluid pre-load (5 mL/Kg), and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 6 mL/Kg/hour.

    Drug: Liberal fluid therapy

Interventions

  • DrugRestrictive fluid therapy

    This group will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2 mL/Kg/hour.

    Also known as: Restrictive fluids

  • DrugLiberal fluid therapy

    This group will receive crystalloid preload of 5 mL/Kg, then will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 6 mL/Kg/hour.

    Also known as: Liberal fluids

06

What researchers measure

Primary outcomes

  1. Incidence of post-dural puncture headache

    the number of patients who develop post-dural puncture headache defined as pain scale above 4

    Time frame: 48 hours

Secondary outcomes

  1. incidence of post-spinal hypotension

    number of patients who develop hypotension defined as decrease of systolic blood pressure by more than 20% from the baseline reading after subarachnoid block

    Time frame: 60 minutes

  2. Wong-Baker faces pain scale

    Pain rating scale which is expressed by the patient starting from zero scale which corresponds to no pain, till scale 10 which corresponds to worst pain

    Time frame: 48 hours

  3. heart rate

    the number of heart beats per minute

    Time frame: 24 hours

  4. postoperative nausea and vomiting

    the number of patients who develop postoperative nausea and vomiting

    Time frame: 24 hours

07

Study locations

1 site
  • Cairo University
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2018 to primary completion in Oct 2018, 7 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2018
First posted
Mar 23, 2018
StartActual
Mar 30, 2018
Primary completionActual
Oct 30, 2018
CompletionActual
Nov 2, 2018
Last update
Aug 20, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03475784
Lead sponsor
Cairo University
Responsible party
Ahmed Hasanin (Assistant professor, Cairo University) — Principal investigator
First posted
Mar 23, 2018
Start date
Mar 30, 2018
Primary completion
Oct 30, 2018
Completion
Nov 2, 2018
Last update
Aug 20, 2019

Study contacts

Tarek Abdelbarr, Professor
study chair · Head of obstetric anesthesia section in anesthesia department

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion